This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Regentree, LLC. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations by Won Suk Yang in Treating Dry Eye Syndrome
Introduction
Won Suk Yang is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of dry eye syndrome. His innovative approaches have the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Won Suk Yang holds a patent for "Methods of treating dry eye syndrome." This patent outlines methods for treating dry eye syndrome (DES) using an effective amount of thymosin beta 4 (Tβ4), along with its fragments, isoforms, derivatives, and peptide agents. The patent specifically mentions amino acid sequences LKKTET [SEQ ID NO: 1] and LKKTNT [SEQ ID NO: 2], or variants thereof. The disclosed methods aim to increase tear volume, enhance tear film stability, reduce ocular surface damage, and alleviate ocular discomfort by delivering compositions of thymosin beta 4 or its fragments to individuals in need.
Career Highlights
Throughout his career, Won Suk Yang has demonstrated a commitment to advancing medical treatments through innovative research. His work has garnered attention in the medical community, particularly for its practical applications in treating dry eye syndrome.
Collaborations
Won Suk Yang has collaborated with notable colleagues, including Sin Wook Kang and Kyoungsun Kim. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
Won Suk Yang's contributions to the treatment of dry eye syndrome exemplify the impact of innovation in healthcare. His patent and collaborative efforts highlight the importance of research in developing effective medical solutions.